Skip to main content

Diagnostic options · UAE

Coagulation Panel tests in Dubai & UAE

Compare available Coagulation Panel tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

6

Listed price range

550.00–4,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Coagulation Panel test prices

Showing 1–6 of 6 matching tests.

Coagulation Panel diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-953
Deep Vein Thrombosis (DVT) Panel Test

This diagnostic test evaluates multiple coagulation factors and markers associated with thrombophilia (inherited or acquired conditions predisposing to blood clots). It assesses th...

Platelet-poor plasma (venous blood) Next-day (sample received by 3 pm) 2,500.00 AED
View
View test specifications and preparation
What it measures
["Protein C", "Protein S", "Antithrombin III", "Factor V Leiden", "Prothrombin G20210A mutation", "D‑dimer", "Lupus Anticoagulant", "Coagulation screen"]
Parameters
[{"name": "Protein C", "reference_range": null}, {"name": "Protein S", "reference_range": null}, {"name": "Antithrombin III", "reference_range": null}, {"name": "Factor V Leiden", "reference_range": null}, {"name": "Prothrombin G20210A mutation", "reference_range": null}, {"name": "D‑dimer", "reference_range": null}, {"name": "Lupus Anticoagulant", "reference_range": null}, {"name": "Complete coagulation screen", "reference_range": null}]
Preparation
["Overnight fasting is preferred", "Discontinue heparin 1 day prior (with physician consent)", "Discontinue oral anticoagulants 7 days prior (with physician consent)", "Provide a completed Coagulation Requisition Form (Form 15)"]
Indications
["Personal or family history of DVT or PE", "Recurrent unexplained thrombosis", "Thrombosis in unusual sites", "Thrombosis during pregnancy or with estrogen use", "Evaluation of hypercoagulable states"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34534-2 ICD-10: I82.9
Clinical summary
This diagnostic test evaluates multiple coagulation factors and markers associated with thrombophilia (inherited or acquired conditions predisposing to blood clots). It assesses the risk of developing deep vein thrombosis.
TEST-1392
Hemophilia Panel Test

This diagnostic test evaluates coagulation factors VIII, IX, and von Willebrand factor to diagnose hemophilia and related bleeding disorders.

Whole Blood (Sodium Citrate) Sample Wed/Sat by 9 am; Report Fri/Tue 600.00 AED
View
View test specifications and preparation
What it measures
["Factor VIII", "Factor IX", "von Willebrand Factor", "Clotting times"]
Parameters
[{"name": "Factor VIII", "reference_range": null}, {"name": "Factor IX", "reference_range": null}, {"name": "von Willebrand Factor", "reference_range": null}]
Preparation
["Overnight fasting is preferred.", "Discontinue Heparin for 1 day prior.", "Discontinue Oral Anticoagulants for 7 days prior (with physician consent).", "A duly filled Coagulation Requisition Form (Form 15) is mandatory."]
Indications
["Patients with unexplained bleeding", "Family history of bleeding disorders", "Pre-surgical evaluation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 6300-4 ICD-10: D66, D67, D68.0
Clinical summary
This diagnostic test evaluates coagulation factors VIII, IX, and von Willebrand factor to diagnose hemophilia and related bleeding disorders.
TEST-2452
Lupus Anticoagulant Panel (LAC Panel) Test

This test evaluates for the presence of lupus anticoagulants, which are antiphospholipid antibodies associated with an increased risk of blood clots.

Whole Blood (Sodium Citrate Tube) Next Day (Sample by 3 PM) 550.00 AED
View
View test specifications and preparation
What it measures
["Antiphospholipid antibodies", "Coagulation pathways (DRVVT, aPTT)"]
Parameters
[{"name": "DRVVT", "reference_range": null}, {"name": "aPTT-based assays", "reference_range": null}]
Preparation
["Overnight fasting preferred", "Inform physician about all anticoagulant medications", "Discontinue heparin 1 day prior (with physician approval)", "Discontinue oral anticoagulants 7 days prior (with physician approval)"]
Indications
["Suspected antiphospholipid syndrome (APS)", "Evaluation of thrombotic risk", "Investigation of recurrent pregnancy loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50466-6 ICD-10: D68.62
Clinical summary
This test evaluates for the presence of lupus anticoagulants, which are antiphospholipid antibodies associated with an increased risk of blood clots.
TEST-2498
Menorrhagia Screen Test

This diagnostic test evaluates the coagulation cascade and platelet function to identify potential bleeding disorders contributing to heavy menstrual bleeding.

Whole Blood (Sodium Citrate) Next day (sample received by Thursday 11 AM) 950.00 AED
View
View test specifications and preparation
What it measures
["Prothrombin Time (PT)", "Activated Partial Thromboplastin Time (aPTT)", "Fibrinogen Levels", "Platelet Function Screening"]
Parameters
[{"name": "Prothrombin Time (PT)", "reference_range": null}, {"name": "Activated Partial Thromboplastin Time (aPTT)", "reference_range": null}, {"name": "Fibrinogen", "reference_range": null}, {"name": "Platelet Function Screening", "reference_range": null}]
Preparation
["Overnight fasting (8–12 hours) is preferred.", "Discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling, only with prior consent from your treating physician.", "A duly filled Coagulation Requisition Form (Form 15) is mandatory."]
Indications
["Evaluation of heavy menstrual bleeding (menorrhagia)", "Suspected underlying bleeding disorder", "Screening for von Willebrand disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34579-9 ICD-10: N92.0
Clinical summary
This diagnostic test evaluates the coagulation cascade and platelet function to identify potential bleeding disorders contributing to heavy menstrual bleeding.
TEST-11
Thrombotic Risk Screen Test

This diagnostic test evaluates multiple genetic and acquired factors contributing to an individual's risk of developing blood clots.

Platelet-poor plasma 5–7 Working Days 2,500.00 AED
View
View test specifications and preparation
What it measures
["Factor V Leiden", "Prothrombin G20210A mutation", "Protein C deficiency", "Protein S deficiency", "Antithrombin III deficiency", "Lupus Anticoagulant", "Coagulation factors"]
Parameters
[{"name": "Factor V Leiden", "reference_range": "Negative/Positive"}, {"name": "Prothrombin G20210A", "reference_range": "Negative/Positive"}, {"name": "Protein C", "reference_range": "Specific range varies by lab"}, {"name": "Protein S", "reference_range": "Specific range varies by lab"}, {"name": "Antithrombin III", "reference_range": "Specific range varies by lab"}, {"name": "Lupus Anticoagulant", "reference_range": "Negative/Positive"}]
Preparation
["Fast overnight (8-12 hours)", "Pause Heparin for 1 day prior (with physician consent)", "Pause Oral Anticoagulants for 7 days prior (with physician consent)", "Ensure special coagulation requisition form (Form 15) is completed"]
Indications
["Personal or family history of venous thromboembolism (VTE)", "Unexplained arterial thrombosis", "Recurrent pregnancy loss", "Pre-operative risk assessment for major surgery", "Evaluation before starting estrogen-containing medications"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83175-6 ICD-10: D68.59
Clinical summary
This diagnostic test evaluates multiple genetic and acquired factors contributing to an individual's risk of developing blood clots.
TEST-3423
Von Willebrand Disease (VWD) Panel Test

This diagnostic test evaluates the levels and function of von Willebrand factor (VWF) and factor VIII, key proteins involved in blood clotting.

Blood (Plasma) Same Day by 6 PM (Sample Received by 11 AM) 4,500.00 AED
View
View test specifications and preparation
What it measures
["von Willebrand factor activity (ristocetin cofactor)", "von Willebrand factor antigen", "factor VIII clotting activity"]
Parameters
[{"name": "VWF Activity (Ristocetin Cofactor)", "reference_range": null}, {"name": "VWF Antigen", "reference_range": null}, {"name": "Factor VIII Clotting Activity", "reference_range": null}]
Preparation
["Overnight fasting is preferred but not mandatory", "Obtain explicit physician consent before temporarily stopping anticoagulant therapy", "Inform the phlebotomist about all medications being taken"]
Indications
["Suspected von Willebrand disease based on clinical history and bleeding assessment", "Family history of VWD", "Pre-operative screening for bleeding risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 58332-7 ICD-10: D68.0
Clinical summary
This diagnostic test evaluates the levels and function of von Willebrand factor (VWF) and factor VIII, key proteins involved in blood clotting.

Category overview

Coagulation Panel: overview

Preparing for a major surgery or safely managing a prescription for blood-thinning medications demands the highest level of precise, overarching diagnostic clarity. Representing a fundamental tool within our Hematology services, the comprehensive Coagulation Panel combines key tests—like PT, aPTT, and INR—to evaluate your overall bleeding and clotting times. Utilizing advanced diagnostic technology, this essential systemic screening provides your medical team with the critical data needed to assess surgical risks, optimize medication dosages, and safely guide your personalized perioperative care. Consistently trusted by surgeons and specialists across top diagnostic labs in Dubai and the UAE, DNA Labs is committed to strict patient confidentiality, exceptional analytical accuracy, and rapid, dependable reporting. Prioritize your medical safety—book your coagulation panel testing in UAE, arrange a convenient home sample collection, or reach out to our dedicated clinical support professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.